← Back to Search

Social media-based education, counseling, and support for Smoking Cessation

N/A
Waitlist Available
Led By Gary Humfleet, PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Daily smoker
Self-identify as sexual and/or gender minority
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 to 6 months
Awards & highlights

Study Summary

This study is evaluating whether a social media-based smoking cessation program may help individuals quit smoking.

Eligible Conditions
  • Smoking Cessation
  • Smoking/Cigarette Smoking
  • Tobacco Use
  • Nicotine Addiction

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 to 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 to 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 3 Months
Number of Participants With Reported 7-day Biochemically Verified Abstinence at 6 Months
Secondary outcome measures
Duration of Active Participation
Frequency of participation in live group sessions
Frequency of social media posts
+2 more

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Pride Posts PlusExperimental Treatment3 Interventions
This six month intervention will include all elements of the Pride Posts arm. In addition, the intervention will include gamification, gaming elements designed to encourage participation in the program and behavior change. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Group II: Pride PostsExperimental Treatment2 Interventions
This six month intervention will be conducted on the Facebook platform. Participants will receive regular social media posts tailored to the sexual and gender minority communities (LGBTQ+). Weekly live sessions with a tobacco expert will be available. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Group III: Usual Care ConditionActive Control1 Intervention
Participants in this arm will be provided with a referral to smokefree.gov, a federally-funded website which provides support and digital-based interventions to assist in smoking cessation activities. Participants will also have access to up to six months of nicotine replacement therapy (patch + gum/lozenge). Dosage will be based manufacturer's recommendations which are based on self-reported smoking behaviors.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Social media-based education, counseling, and support
2020
N/A
~130

Find a Location

Who is running the clinical trial?

Tobacco Related Disease Research ProgramOTHER
25 Previous Clinical Trials
20,497 Total Patients Enrolled
University of California, San FranciscoLead Sponsor
2,493 Previous Clinical Trials
11,931,677 Total Patients Enrolled
Gary Humfleet, PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who else is applying?

What state do they live in?
California
How old are they?
18 - 65
What site did they apply to?
University of California, San Francisco
What portion of applicants met pre-screening criteria?
Met criteria
~25 spots leftby Mar 2025